| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Revenue | $6.27B | -1.5% |
| Cost of Revenue | $1.83B | -14.8% |
| Gross Profit | $4.43B | +5.3% |
| R&D Expense | $1.03B | +7.6% |
| SG&A Expense | $308.0M | +16.2% |
| Operating Income | $1.21B | +19.3% |
| Interest Expense | $64.0M | -4.5% |
| Pre-tax Income | $1.26B | +18.5% |
| Income Tax | $277.0M |
| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.90B | -17.8% |
| Short-term Investments | $1.35B | +78.9% |
| Accounts Receivable | $1.01B | +2.0% |
| Inventory | $186.0M | +11.4% |
| Current Assets | $4.90B | +4.6% |
| Total Assets | $9.89B | +0.7% |
| Current Liabilities | $4.11B | +18.4% |
| Line Item | 2024-04-26 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.69B | +52.2% |
| Capital Expenditures | $155.0M | -35.1% |
| Investing Cash Flow | -$735.0M | +47.1% |
| Financing Cash Flow | -$1.34B | +11.2% |
| Free Cash Flow | $1.53B | +76.3% |
| +233.2% |
| Net Income | $986.0M | -22.6% |
| EPS (Basic) | $4.74 | -19.3% |
| EPS (Diluted) | $4.63 | -20.0% |
| Long-term Debt |
| $2.39B |
| +0.1% |
| Total Liabilities | $8.74B | +0.9% |
| Stockholders' Equity | $1.15B | -1.1% |